Structure via PubChem · Public domain (PubChem)
climazolam
Sign in to saveClimazolam (Ro21-3982) was introduced under licence as a veterinary medicine by the Swiss Pharmaceutical company Gräub under the tradename Climasol. Climazolam is a benzodiazepine, specifically an imidazobenzodiazepine derivative developed by Hoffman-LaRoche. It is similar in structure to midazolam and diclazepam and is used in veterinary medicine for anesthetizing animals.
In the Vinony graph
Vinony's link graph records 636 inbound references to climazolam, and connects out to benzodiazepine drug, alphenal and zapizolam.
It sits within the topics 2-Chlorophenyl compounds, Chemical pages without DrugBank identifier and GABAA receptor positive allosteric modulators.
Vinony links it to 8 Wikipedia language editions.
Chemical data
- Formula
- C18H13Cl2N3
- Molecular weight
- 342.2 g/mol
- IUPAC name
- 8-chloro-6-(2-chlorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
- SMILES
- CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
- InChIKey
- CHCISLOJADQUNQ-UHFFFAOYSA-N
- XLogP
- 3
- Polar surface area
- 30.2 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 341.049
Show 3 more facts
- chemical formula
- C₁₈H₁₃Cl₂N₃
- canonical SMILES
- CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
- Commons category
- Climazolam
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Climazolam (Ro21-3982) was introduced under licence as a veterinary medicine by the Swiss Pharmaceutical company Gräub under the tradename Climasol. Climazolam is a benzodiazepine, specifically an imidazobenzodiazepine derivative developed by Hoffman-LaRoche. It is similar in structure to midazolam and diclazepam and is used in veterinary medicine for anesthetizing animals.
==References==
Excerpted from Wikipedia’s “climazolam” article, available under the CC BY-SA 4.0 licence.